Impact of the menstrual cycle on commercial prognostic gene signatures in oestrogen receptor-positive primary breast cancer.
Haynes BP, Schuster G, Buus R, Alataki A, Ginsburg O, Quang LH, Han PT, Khoa PH, Van Dinh N, Van To T, Clemons M, Holcombe C, Osborne C, Evans A, Skene A, Sibbering M, Rogers C, Laws S, Noor L, Cheang MCU, Cleator SJ, Smith IE, Dowsett M.
Haynes BP, et al. Among authors: cleator sj.
Breast Cancer Res Treat. 2021 Nov;190(2):295-305. doi: 10.1007/s10549-021-06377-3. Epub 2021 Sep 15.
Breast Cancer Res Treat. 2021.
PMID: 34524591
Free PMC article.